# US 2025/0144390 A1 · Medical device for ultrasound-assisted drug delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144390 A1
- Document ID: US20250144390A1
- Status: Published application
- Kind: A1
- Application number: 18/933,501
- Filed: 2024-10-31
- Published: 2025-05-08
- Earliest claimed: 2023-11-03
- Assignees: Boston Scientific Scimed, Inc.
- Applicants: Boston Scientific Scimed, Inc.
- Inventors: Benjamin Montag; Curtis Cornell Genstler; Noah Chan Ridge; Zachary Balsiger; Vidhya Ramaswamy
- Web page: https://patentgrep.com/patent/US20250144390A1

## CPC

- A61M 37/0092: {using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis}
- A61B 17/2202: {the ultrasound transducer being inside patient's body at the distal end of the catheter}
- A61M 2202/0007: introduced into the body
- A61M 2202/0468: non-physiological
- A61M 2205/10: with powered movement mechanisms
- A61M 2205/33: Controlling, regulating or measuring
- A61M 2205/50: with microprocessors or computers
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Systems and methods for treating a vascular region are disclosed. An example system for treating a vascular region may include an elongate catheter shaft having a distal end region. A central lumen may be formed in the elongate catheter shaft. A treatment core may be disposed within the central lumen. The treatment core may include a plurality of ultrasound transducers. A control unit may be coupled to the treatment core. The control unit may be configured to shift between in a first configuration. A fluid delivery lumen may be defined in the elongate catheter shaft. A pump may be coupled to the elongate catheter shaft. The pump may be configured to deliver microbubbles, nanodroplets, or both to the fluid delivery lumen when the control unit is in the inactive state.

## Claims

### Claim 1

A system for treating a vascular region, the system comprising:
an elongate catheter shaft having a distal end region;
wherein a central lumen is formed in the elongate catheter shaft;
a treatment core disposed within the central lumen, the treatment core including a plurality of ultrasound transducers disposed adjacent to the distal end region of the elongate catheter shaft;
a control unit coupled to the treatment core, the control unit being configured to shift between in a first configuration where the plurality of ultrasound transducers are in an active state and a second configuration where the plurality of ultrasound transducers are in an inactive state;
a fluid delivery lumen defined in the elongate catheter shaft; and
a pump coupled to the elongate catheter shaft, the pump being configured to deliver microbubbles, nanodroplets, or both to the fluid delivery lumen when the ultrasound transducers are in the inactive state.

### Claim 2 (depends on 1)

The system of claim 1, wherein the pump is configured to deliver saline through the fluid delivery lumen when the when the ultrasound transducers are in the active state.

### Claim 3 (depends on 1)

The system of claim 1, wherein the pump includes a switch.

### Claim 4 (depends on 3)

The system of claim 3, wherein the switch is configured to switch between a first switch configuration where the pump delivers microbubbles, nanodroplets, or both to the fluid delivery lumen and a second switch configuration where the pump delivers saline to the fluid delivery lumen.

### Claim 5 (depends on 1)

The system of claim 1, wherein when the control unit is in the first configuration, the plurality of ultrasound transducers are in the active state for about 10-60 seconds.

### Claim 6 (depends on 1)

The system of claim 1, wherein when the control unit is in the first configuration, the plurality of ultrasound transducers are in the active state for about 15-45 seconds.

### Claim 7 (depends on 1)

The system of claim 1, wherein when the control unit is in the first configuration, the plurality of ultrasound transducers are in the active state for about 30 seconds.

### Claim 8 (depends on 1)

The system of claim 1, wherein when the control unit is in the second configuration, the plurality of ultrasound transducers are in the inactive state for about 10-60 seconds.

### Claim 9 (depends on 1)

The system of claim 1, wherein when the control unit is in the second configuration, the plurality of ultrasound transducers are in the inactive state for about 15-45 seconds.

### Claim 10 (depends on 1)

The system of claim 1, wherein when the control unit is in the second configuration, the plurality of ultrasound transducers are in the inactive state for about 30 seconds.

### Claim 11 (depends on 1)

The system of claim 1, wherein the pump is configured to not deliver microbubbles, nanodroplets, or both to the fluid delivery lumen when the ultrasound transducers are in the active state.

### Claim 12

A system for treating a vascular region, the system comprising:
an elongate catheter shaft;
a treatment core disposed within the elongate catheter shaft, the treatment core including a plurality of ultrasound transducers;
a control unit coupled to the treatment core, the control unit being configured to shift between in a first state where the plurality of ultrasound transducers are active and a second state where the plurality of ultrasound transducers are inactive;
a fluid delivery lumen defined in the elongate catheter shaft; and
a pump coupled to the elongate catheter shaft, wherein the pump is configured to deliver microbubbles, nanodroplets, or both to the fluid delivery lumen when the control unit is in the first state and wherein the pump is configured to not deliver microbubbles, nanodroplets, or both to the fluid delivery lumen when the control unit is in the second state.

### Claim 13 (depends on 12)

The system of claim 12, wherein the pump is configured to deliver saline through the fluid delivery lumen when the control unit is in the second state.

### Claim 14 (depends on 12)

The system of claim 12, wherein the pump includes a switch.

### Claim 15 (depends on 14)

The system of claim 14, wherein the switch is configured to switch between a first switch configuration when the control unit is in the first state so that the pump delivers microbubbles, nanodroplets, or both to the fluid delivery lumen and a second switch configuration when the control unit is in the second state so that the pump delivers saline to the fluid delivery lumen.

### Claim 16 (depends on 12)

The system of claim 12, wherein when the control unit is in the first state, the plurality of ultrasound transducers are active for about 10-60 seconds.

### Claim 17 (depends on 12)

The system of claim 12, wherein when the control unit is in the first state, the plurality of ultrasound transducers are active for about 15-45 seconds.

### Claim 18 (depends on 12)

The system of claim 12, wherein when the control unit is in the first state, the plurality of ultrasound transducers are active for about 30 seconds.

### Claim 19 (depends on 12)

The system of claim 12, wherein when the control unit is in the second state, the plurality of ultrasound transducers are inactive for about 10-60 seconds.

### Claim 20

A method for delivering a drug to a vascular region, the method comprising:
advancing a catheter system to a treatment site, the catheter system comprising:
an elongate catheter shaft having a distal end region,
wherein a central lumen is formed in the elongate catheter shaft,
a treatment core disposed within the central lumen, the treatment core including a plurality of ultrasound transducers disposed adjacent to the distal end region of the elongate catheter shaft,
a control unit coupled to the treatment core, the control unit being configured to shift between in a first configuration where the plurality of ultrasound transducers are in an active state and a second configuration where the plurality of ultrasound transducers are in an inactive state,
a fluid delivery lumen defined in the elongate catheter shaft, and
a pump coupled to the elongate catheter shaft, the pump being configured to deliver microbubbles, nanodroplets, or both to the fluid delivery lumen when the control unit is in the inactive state;
advancing the treatment core through the central lumen so that the plurality of ultrasound transducers are disposed adjacent to the distal end region of the elongate catheter shaft;
delivering microbubbles, nanodroplets, or both to the fluid delivery lumen when the control unit is in the inactive state; and
activating at least some of the plurality of ultrasound transducers.
